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Background
The first intuitions on the existence of a link between increased
urinary calcium excretion and nephrolithiasis date back to the
nineteen-thirties, but the concept of hypercalciuria was defined
only twenty years later. Hodgkinson and Pirah defined, as nor-
mal, urinary calcium levels of up to 250 mg/day for females and
300 mg/day for males, or levels of up to 4 mg/kg body weight,
regardless of sex and age. According to this criterion, the one
most followed even today, approximately 50% of patients with
idiopathic calcium nephrolithiasis show hypercalciuria, as op-
posed to 2-5% of the healthy population (1). Excess in urinary
calcium excretion was originally attributed to increased intesti-
nal cation absorption (2).
When PTH assay became available, from low to frankly elevat-
ed PTH levels were reported in hypercalciuric stone formers.
The hypothesis that a primitive renal calcium leak could be re-
sponsible for the secondary hyperparathyroidism observed in
some cases, lead to the definition of renal hypercalciuria,
alongside the previously described absorptive hypercalciuria
(3). The hypocalciuric and hypercalcemic effects of thiazide di-
uretics were described in 1966 and it later became widely ac-
cepted that the reduction of urinary calcium excretion induced
by thiazides could have been associated to an increased calci-
um deposition in bone (4,5). Furthermore, epidemiological
studies demonstrated a reduction of fracture risk in hyperten-
sive patients who were taking these drugs (6).
In the first half of the 1980’s, the possibility of assaying serum
calcitriol confirmed most of the pathophysiologic hypotheses on
hypercalciuria until so far suggested (7). Hypercalciuric syn-
dromes were thus classified in three main categories according
to Pak’s classic description: (a) hyperabsorptive hypercalciuria
when the high calcium excretion lowered to normal values
while on a low-calcium diet or on a supplementation with calci-
um-chelating agents such as cellulose phosphate; (b) r nal hy -
p e r c a l c i u r i a characterized by elevated fasting calcium excre-
tion, with tendency toward hypocalcemia and secondary hyper-
parathyroidism; and (c) resorptive hypercalciuria consequent to
primitive parathyroid hypersecretion and characterized by fast-
ing hypercalciuria, increased bone turnover and reduced bone
mineral density (3).
In the followings years however, it became evident that in pa-
tients with the so-called renal hypercalciuria, that is fasting hy-
percalciuria with normal serum calcium levels, a secondary hy-
perparathyroidism was rare (3). Thus, the term fasting hyper -
calciuria was suggested by some authors in place of renal hy-
percalciuria (8). In fact, a hypercalciuria due to primitive renal
loss remains, nonetheless, a confirmed physiopathological en-
tity, both at experimental level in mice as well as in some
hereditary forms in man (9,11). This changed attitude in regard
to renal hypercalciuria resolved essentially in the drastic reap-
praisal of its attributed role within the scope of idiopathic hyper-
calciuria (8).
During these same years, studies in man confirmed previous
hypotheses according to which patients affected by idiopathic
hypercalciuria showed, without exception, an increased intesti-
nal absorption of calcium. However, these studies revealed
that intestinal hyperabsorption of calcium per se was unable to
justify hypercalciuria, because more than half of the cases
studied showed a urinary calcium excretion greater than the
amount absorbed (12). 
Investigations performed by means of X-ray absorptiometry re-
ported, albeit with significant controversies, reduced levels of
bone mass in hypercalciuric subjects, with greater prevalence
of osteopenia in subjects with fasting hypercalciuria, as op-
posed to subjects with normal urinary calcium or those with ab-
sorptive hypercalciuria (13,14).
On the basis of such clinical and experimental evidences in the
last two decades a radical rethinking has occurred on the role of
bone metabolism alterations in idiopathic hypercalciuria. It is now
widely accepted that bone can be a primitive source of hypercal-
ciuria not caused by primitive parathyroid stimulation, even if the
mount of calcium originating directly from bone can not entirely
account for the total quantity of urinary calcium that hypercalci-
uric subjects eliminate in excess compared to normal individuals.
Numerous studies in the last twenty years showed that pat-
terns of calcium excretion are distributed according to a contin-
uum both in normal and stone forming subjects. That does not
allow a clearcut differentiation of the causal mechanisms. 
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Currently it seems more appropriate to consider primary hyper-
calciuria as an aggregate of complex clinical features, due to
the varying contribution of different pathophysiologic mecha-
nisms, namely intestinal hyperabsorption, renal leak and bone
reabsorption.
Therefore, it appears that hypercalciuria should not be viewed
as an organ-related disease any more. Rather, it must be con-
sidered as an expression of complex mineral metabolism alter-
ations encompassing nephrology, endocrinology, and osteolo-
gy specialities.
On the basis of these observations a heterogeneous group of
specialists collaborated in promoting a true interdisciplinary ap-
proach to primitive hypercalciuria, through a critical re-exami-
nation of the main diagnostic criteria and procedures*. This
could make possible to reach a consensus on a first-level clini-
cal approach in patients with primitive hypercalciuria, on the
basis of which it might be easier to build-up a protocol for the
subsequent clinical investigations.
In this first temptative some significant points of agreement in
regard to previous reports on primitive hypercalciuria emerged
(1). These latter may constitute a worthwhile opportunity for
thought and subsequent investigations by the international sci-
entific community.
Question #1 
Is it advisable to redefine the normal levels of calciuria, referred
to different phases of life (i.e. childhood, adulthood, elderly,
pregnancy and menopause)?
The current upper limits of normality, for calcium excretion (300
mg/24 h in males and 250 mg/24 h in females; 4 mg/kg body
weight or 0.20 mg/24 h per mg of urinary creatinine in both
sexes) have been defined in a healthy adult population, in a
particular geographic context, and have not been corrected for
dietetic intake (1).
This fact reduces the reliability of these limits, especially in cer-
tain age segments, such as in infancy and senility. In fact, the
different indexes of calcium excretion, determined in a sample
essentially made up of healthy adult individuals, are less ap-
plicable in other age segments characterized by relevant differ-
ences in the main body parameters (i.e. body surface area,
adipose tissue and lean mass).
Thus it would be worthwhile to reconsider these parameters of
normality through epidemiological studies on healthy popula-
tions of different age. This could make possible to obtain infor-
mation beyond the entity of calcium excretion also on the gen-
eral style of diet, with particular reference to the intake of calci-
um, sodium and animal proteins.
It would be important to integrate these data with information
on the coexistent estrogenic and calciotropic hormonal status.
Question #2 
Advantages and limitations of calcium excretion measure -
ments. Which indices are deemed most appropriate for a diag -
nosis of hypercalciuria (i.e. 24 hour calcium excretion, 24 hour
and fasting calcium to creatinine ratio and 24 hour urine calci-
um/kg body weight)?
In general terms, it is advisable to assess all the above para-
meters in each patient and, when one of these indices is above
threshold level, define the subject as having hypercalciuria. For
further categorization of hypercalciuria (renal, reabsorptive, hy-
perabsorptive, etc.), the above parameters must be integrated
with additional metabolic indicators (ionized serum calcium,
bone alkaline phosphatase, PTH, urine pyridinoline to creati-
nine ratio, TmPO4, vitamin D metabolites).
Question #3
Standardization of urine collection for the assessment of calci -
um excretion. 
For reliable determination of calcium in urine collections, the
precipitation of slightly soluble calcium salts must be avoided.
This can be obtained by means of preliminary acidification of
the sample, aimed at obtaining pH values around 3. If urine
has also to be assayed for oxalate, further reduction of pH until
2 is advisable. 
For this purpose, 24 hour urine can be collected in plastic con-
tainers previously filled with concentrated HCl solution (for ex-
ample, 10 mL HCl at 37%, or 20 mL at 10%).
Conversely, if acidification is carried out at the end of the 24
hour collection, an adequate solubilization of the oxalate calci-
um salts requires both acidification to pH 1 and heating of the
sample.
F r pediatric urinary collections, the employment of high con-
centration and condensed volume HCl is recommended to
avoid dilutional effects on the sample.
If the urinary collection is aimed to the study of supersaturation
with stone-forming salts, it is necessary to avoid the interfer-
ence of the preliminary acidification on some urinary compo-
nents (i.e. pH, chloride and uric acid). For this purpose, each
sample should be exposed to two different conditions (i.e. 10-
20 mL of HCl and 5 mL of a neutral preservative, such as
chlorexidine).
Question #4 
Which exams should be performed when a syndrome of hyper -
calciuria has been identified?
In other words, the problem is to define whether bone metabo-
lism must somehow be investigated in hypercalciuric patients
with nephrolithiasis and, conversely, whether nephrologic as-
sessment must be performed in patients in which the diagnosis
of hypercalciuria has come about during an osteometabolic
evaluation.
An abnormal urinary excretion of calcium is a metabolic feature
that is not shared by the major part of the population. Thus, it
must be considered a biological marker that deserves clinical
observation.
The prevailing opinion is that patients with fasting hypercalci-
uria, beside  accurate investigation on the main nephrologic
and osteometabolic risk factors, should be further evaluated by
means of bone densitometry, renal echography and first-level
biochemical assessment of mineral metabolism, as urea and
creatinine clearances; serum and urinary sodium, potassium,
calcium and phosphate; serum ionized calcium; serum protein
electrophoresis; bone alkaline-phosphatase; and fasting urine,
calcium, creatinine and pyridinoline.
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* This Consensus document is from the First Florentine Seminar on Mineral Metabolism held December 14, 2001 in Florence, Italy. It also includes
components from subsequent discussions.
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